Detalhe da pesquisa
1.
Translocated microbiome composition determines immunological outcome in treated HIV infection.
Cell
; 184(15): 3899-3914.e16, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34237254
2.
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).
Gene Ther
; 30(3-4): 216-221, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34493840
3.
Phase 2 Open-Label Study of Long-Term Safety, Tolerability, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive Adolescents Living with HIV-1.
Antimicrob Agents Chemother
; 66(2): e0091621, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34871089
4.
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.
AIDS Res Ther
; 18(1): 17, 2021 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33882938
5.
Correction: Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI).
Gene Ther
; 30(3-4): 405, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34584245
6.
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
J Antimicrob Chemother
; 72(4): 1152-1162, 2017 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28062682
7.
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
J Antimicrob Chemother
; 69(12): 3329-34, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25147095
8.
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
PLoS Med
; 9(6): e1001236, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22719231
9.
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297).
J Acquir Immune Defic Syndr
; 89(2): 178-182, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34693933
10.
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.
Trop Med Int Health
; 16(2): 200-4, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21091860
11.
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda.
BMJ Open Respir Res
; 8(1)2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34376401
12.
Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
PLoS One
; 16(6): e0252306, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34138909
13.
Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.
Antivir Ther
; 14(2): 293-7, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19430104
14.
Women, economic hardship and the path of survival: HIV/AIDS risk behavior among women receiving HIV/AIDS treatment in Uganda.
AIDS Care
; 21(3): 355-67, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19280411
15.
The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.
AIDS Res Ther
; 6: 17, 2009 Jul 24.
Artigo
Inglês
| MEDLINE | ID: mdl-19630949
16.
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues.
J Acquir Immune Defic Syndr
; 81(3): 355-360, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31192893
17.
Lymphoid tissue fibrosis is associated with impaired vaccine responses.
J Clin Invest
; 128(7): 2763-2773, 2018 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29781814
18.
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
AIDS
; 21(6): 733-7, 2007 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-17413694
19.
Defining total-body AIDS-virus burden with implications for curative strategies.
Nat Med
; 23(11): 1271-1276, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28967921
20.
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Antivir Ther
; 11(6): 741-9, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17310818